Philadelphia announced a new lawsuit Tuesday against three major drug manufacturers and three pharmacy benefit managers. The city alleges all six are complicit in an insulin pricing scheme to keep the ...
Australian Associated Press on MSN
Weight loss drugs could get cheaper from next year
The government is considering expanding taxpayer subsidies for Ozempic-style drugs, despite concerns about possible ...
Weight loss medication Wegovy may soon be cheaper for thousands of people after the Pharmaceutical Benefits Advisory ...
The commonwealth claims that pharmacy benefit managers and drug manufacturers are in cahoots to inflate insulin prices for ...
Patients with an aggressive form of breast cancer could soon save thousands of dollars every month, as the government ...
Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...
President Donald Trump revealed a significant agreement this Friday with nine of the globe's largest pharmaceutical companies ...
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.
Tucatinib, a breast cancer drug, will be listed on PBS, saving patients over $4,500 per monthThe drug is specifically for HER2-positive ...
A daily weight-loss pill will soon be available in the US, after the regulator gave approval to Danish drug company Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback